Author(s) Lok, C; Paul, C; Amblard, P; Bessis, D; Debure, C; Faivre, B; Guillot, B; Ortonne, J P; Huledal, G; Kalis, B, et al.

Journal Journal of the American Academy of Dermatolog.... Date of publication 1999 Feb 1;volume 40(2 Pt 1):208-213.

Abstract BACKGROUND: A granulating surface is important for skin grafting and healing of leg ulcers. Mechanical debridement to remove necrotic tissue often must be stopped before completion because of pain. OBJECTIVE: Our purpose was to assess the effect of EMLA cream on the number of debridements required to obtain a clean ulcer and on pain during debridement and to determine its safety after repeated doses. METHODS: In this randomized double-blind, placebo-controlled study, 69 patients with venous leg ulcers received cream before debridement until a clean ulcer was obtained (or a maximum of 15 debridements). RESULTS: EMLA decreased the median number of debridements required for a clean ulcer (EMLA 11.5, placebo >15; P = .019) and decreased pain by 50% (P = .003). Plasma levels of lidocaine, prilocaine, and their main metabolites were low without any apparent accumulation. CONCLUSION: EMLA produces effective pain relief for the debridement of leg ulcers and shortens the time to a clean ulcer.

Source ID (e.g. PMID): 10025747